1.Clinical and genetic analysis of a Chinese pedigree with autosomal recessive familial intrahepatic cholestasis type I due to a novel variant of ATP8B1 gene.
Zhimin WANG ; Haili QI ; Xiaojuan WEI ; Hualing DUAN ; Xiaohuan LI ; Hongyang QI
Chinese Journal of Medical Genetics 2025;42(5):608-612
OBJECTIVE:
To investigate the clinical and genetic features of a Chinese pedigree with Progressive familial intrahepatic cholestasis (PFIC) and explore its genotype-phenotype correlation.
METHODS:
A patient with PFIC diagnosed at Xinxiang Central Hospital in 2023 was selected as the study subject. The patient was subjected to abdominal magnetic resonance imaging (MRI) and painless gastroscopy. Peripheral blood samples were collected from the patient and his parents for the extraction of genomic DNA and trio-whole exome sequencing (trio-WES). Candidate variants were verified by Sanger sequencing. This study has been approved by the Medical Ethics Committee of Xinxiang Hospital (Ethics No. 2023-241).
RESULTS:
MRI scan showed that the patient had significantly enlarged liver and spleen. WES revealed that he has harbored compound heterozygous variants of the ATP8B1 gene, including a c.1710_1711insCCTC (p.A571Pfs*12) frameshifting variant in exon 16 and a c.2989G>A (p.V997M) missense variant in exon 24, which were respectively inherited from his father and mother, and rated as pathogenic (PVS1+PM2_Supporting+PM3+PP1) and likely pathogenic (PM2_Supporting+PM3+PP1) based on the guidelines from the American College of Medical Genetics and Genomics (ACMG).
CONCLUSION
WES can clarify the genetic etiology of patients with speed and accuracy, and facilitate clinical decision-making. The detection of pathogenic variants has provided a basis for clinical diagnosis and enriched the mutational spectrum of the ATP8B1 gene.
Humans
;
Male
;
Pedigree
;
Cholestasis, Intrahepatic/diagnostic imaging*
;
Adenosine Triphosphatases/genetics*
;
Female
;
Adult
;
Exome Sequencing
;
Mutation
;
East Asian People
2.Clinical and genetic analysis of a Chinese pedigree with autosomal recessive familial intrahepatic cholestasis type Ⅰ due to a novel variant of ATP8B1 gene
Zhimin WANG ; Haili QI ; Xiaojuan WEI ; Hualing DUAN ; Xiaohuan LI ; Hongyang QI
Chinese Journal of Medical Genetics 2025;42(5):608-612
Objective:To investigate the clinical and genetic features of a Chinese pedigree with Progressive familial intrahepatic cholestasis (PFIC) and explore its genotype-phenotype correlation.Methods:A patient with PFIC diagnosed at Xinxiang Central Hospital in 2023 was selected as the study subject. The patient was subjected to abdominal magnetic resonance imaging (MRI) and painless gastroscopy. Peripheral blood samples were collected from the patient and his parents for the extraction of genomic DNA and trio-whole exome sequencing (trio-WES). Candidate variants were verified by Sanger sequencing. This study has been approved by the Medical Ethics Committee of Xinxiang Hospital (Ethics No. 2023-241).Results:MRI scan showed that the patient had significantly enlarged liver and spleen. WES revealed that he has harbored compound heterozygous variants of the ATP8B1 gene, including a c. 1710_1711insCCTC (p.A571Pfs*12) frameshifting variant in exon 16 and a c. 2989G>A (p.V997M) missense variant in exon 24, which were respectively inherited from his father and mother, and rated as pathogenic (PVS1+ PM2_Supporting+ PM3+ PP1) and likely pathogenic (PM2_Supporting+ PM3+ PP1) based on the guidelines from the American College of Medical Genetics and Genomics (ACMG). Conclusion:WES can clarify the genetic etiology of patients with speed and accuracy, and facilitate clinical decision-making. The detection of pathogenic variants has provided a basis for clinical diagnosis and enriched the mutational spectrum of the ATP8B1 gene.
3.Differences in the self-perceived burden of gastric cancer patients at different time points and its relationship with family care and self-management efficacy
Yan JIANG ; Hua GUO ; Hongyang QI ; Yang LI ; Ling ZHAO ; Xiaohuan LI
Chinese Journal of Modern Nursing 2025;31(20):2748-2753
Objective:To explore the differences in the self-perceived burden of gastric cancer patients at different treatment time points and its relationship with family care and self-management efficacy, providing a reference for developing interventions to reduce self-perceived burden in gastric cancer patients.Methods:A convenience sampling method was used to select 151 gastric cancer patients who were hospitalized in the Department of Gastroenterology at Xinxiang Central Hospital from January 2022 to March 2024. Surveys were conducted at four time points: one day before surgery (T 1), after surgery and before the first chemotherapy (T 2), after the third chemotherapy (T 3), and after the sixth chemotherapy (T 4). The Self-Perceived Burden Scale, Family APGAR Index, and Chinese version of the Strategies Used by People to Promote Health were used. Repeated measures analysis of variance was applied to examine the trend of score changes at different time points, and multiple linear regression analysis was performed to explore the relationship between family care, self-management efficacy, and self-perceived burden at each time point. Results:The self-perceived burden scores of gastric cancer patients at the four time points were (31.11±7.86), (32.44±7.78), (33.44±7.45), and (33.17±7.06), respectively. Family care showed a negative impact on the self-perceived burden of patients at all four time points (standardized regression coefficients were -0.148, -0.733, -0.180, -0.218; P<0.05). Self-management efficacy also had a negative impact on the self-perceived burden at all four time points (standardized regression coefficients were -0.792, -0.209, -0.445, -0.402; P<0.05) . Conclusions:The self-perceived burden of gastric cancer patients increases gradually during treatment. Both family care and self-management efficacy negatively affect the self-perceived burden. Healthcare professionals should pay attention to the changes in self-perceived burden and its influencing factors during the treatment process, and develop targeted interventions to improve patients' self-perceived burden and quality of life.
4.Differences in the self-perceived burden of gastric cancer patients at different time points and its relationship with family care and self-management efficacy
Yan JIANG ; Hua GUO ; Hongyang QI ; Yang LI ; Ling ZHAO ; Xiaohuan LI
Chinese Journal of Modern Nursing 2025;31(20):2748-2753
Objective:To explore the differences in the self-perceived burden of gastric cancer patients at different treatment time points and its relationship with family care and self-management efficacy, providing a reference for developing interventions to reduce self-perceived burden in gastric cancer patients.Methods:A convenience sampling method was used to select 151 gastric cancer patients who were hospitalized in the Department of Gastroenterology at Xinxiang Central Hospital from January 2022 to March 2024. Surveys were conducted at four time points: one day before surgery (T 1), after surgery and before the first chemotherapy (T 2), after the third chemotherapy (T 3), and after the sixth chemotherapy (T 4). The Self-Perceived Burden Scale, Family APGAR Index, and Chinese version of the Strategies Used by People to Promote Health were used. Repeated measures analysis of variance was applied to examine the trend of score changes at different time points, and multiple linear regression analysis was performed to explore the relationship between family care, self-management efficacy, and self-perceived burden at each time point. Results:The self-perceived burden scores of gastric cancer patients at the four time points were (31.11±7.86), (32.44±7.78), (33.44±7.45), and (33.17±7.06), respectively. Family care showed a negative impact on the self-perceived burden of patients at all four time points (standardized regression coefficients were -0.148, -0.733, -0.180, -0.218; P<0.05). Self-management efficacy also had a negative impact on the self-perceived burden at all four time points (standardized regression coefficients were -0.792, -0.209, -0.445, -0.402; P<0.05) . Conclusions:The self-perceived burden of gastric cancer patients increases gradually during treatment. Both family care and self-management efficacy negatively affect the self-perceived burden. Healthcare professionals should pay attention to the changes in self-perceived burden and its influencing factors during the treatment process, and develop targeted interventions to improve patients' self-perceived burden and quality of life.
5.Clinical and genetic analysis of a Chinese pedigree with autosomal recessive familial intrahepatic cholestasis type Ⅰ due to a novel variant of ATP8B1 gene
Zhimin WANG ; Haili QI ; Xiaojuan WEI ; Hualing DUAN ; Xiaohuan LI ; Hongyang QI
Chinese Journal of Medical Genetics 2025;42(5):608-612
Objective:To investigate the clinical and genetic features of a Chinese pedigree with Progressive familial intrahepatic cholestasis (PFIC) and explore its genotype-phenotype correlation.Methods:A patient with PFIC diagnosed at Xinxiang Central Hospital in 2023 was selected as the study subject. The patient was subjected to abdominal magnetic resonance imaging (MRI) and painless gastroscopy. Peripheral blood samples were collected from the patient and his parents for the extraction of genomic DNA and trio-whole exome sequencing (trio-WES). Candidate variants were verified by Sanger sequencing. This study has been approved by the Medical Ethics Committee of Xinxiang Hospital (Ethics No. 2023-241).Results:MRI scan showed that the patient had significantly enlarged liver and spleen. WES revealed that he has harbored compound heterozygous variants of the ATP8B1 gene, including a c. 1710_1711insCCTC (p.A571Pfs*12) frameshifting variant in exon 16 and a c. 2989G>A (p.V997M) missense variant in exon 24, which were respectively inherited from his father and mother, and rated as pathogenic (PVS1+ PM2_Supporting+ PM3+ PP1) and likely pathogenic (PM2_Supporting+ PM3+ PP1) based on the guidelines from the American College of Medical Genetics and Genomics (ACMG). Conclusion:WES can clarify the genetic etiology of patients with speed and accuracy, and facilitate clinical decision-making. The detection of pathogenic variants has provided a basis for clinical diagnosis and enriched the mutational spectrum of the ATP8B1 gene.
6.Exercise-induced chronic fatigue impairs working memory in rats via basal ganglia output nuclei
Shuo JIN ; Hongyang LI ; Chenxuan JI ; Jinshun QI ; Lina SUN
Chinese Journal of Neuroanatomy 2024;40(1):9-15
Objective:To investigate possible neuromodulatory mechanisms involved in the involvement of parvalbu-min(PV)expression in the basal ganglia output nuclei,entopeduncular nucleus(EPN)and substantia nigra pars etic-ulata(SNr),in exercise-induced chronic fatigue impairs working memory capacity.Methods:Male SD rats were divid-ed into control group and Fatigue group by random number method,and a three-stage incremental load treadmill training program was selected to establish a chronic exhaustion exercise-induced fatigue rat model.The working memory ability of rats was assessed by the Y-maze autonomous alternation experiment.Immunohistochemical staining was used to ob-serve the expression of parvalbumin(PV)positive neurons and cysteine aspartate-specific protease-3(caspase-3)in EPN and SNr of rats.Results:The accuracy of voluntary alternation in the fatigue group was obviously lower than that in control group(P<0.05).The results of immunohistochemical staining showed that the density of PV positive neu-rons and the degree of positive fiber staining in EPN and SNr in the fatigue group were obviously lower than those in the control group(P<0.05,P<0.01).The number of caspase-3 positive cells per unit area of EPN and SNr in the fa-tigue group was obviously higher than that in the control group(P<0.05,P<0.01).Conclusion:The mechanism of impairing working memory in rats caused by exercise-induced chronic fatigue may be related to the apoptosis of PV posi-tive neurons in EPN and SNr.
7.Retrospective study on authorized aeromedical identification of overage military flying personnel
Nan SU ; Di ZHU ; Linsong QI ; Jiakang ZHANG ; Dongrui YU ; Jun WANG ; Junhua XING ; Hongyang JI ; Xianrong XU
Space Medicine & Medical Engineering 2024;35(2):112-115
Objective To retrospectively investigate and analyze the specially permitted aeromedical evaluation results of overage military flying personnel,in order to provide references for health management and related evaluation methods improvement.Methods The clinical data and evaluation results of overage flying personnel were collected from 2012 to 2023.Disease spectrum was analyzed,and qualified rates among different airplane types and aviation duties were compared.Results 79.57%of the 509 flying personnel were detected with diseases,and the top ten were hyperlipidemia,fatty liver,thyroid nodule,renal cyst,hepatic cyst,gallbladder polyps,hyperuricemia,carotid artery arteriosclerosis,hypertension and hepatic hemangioma.96.08%of the personnel were qualified to continue flying,1.96%were disqualified and 1.96%were temporarily disqualified.The qualified rates among different airplane types and aviation duties were not significantly different(P?>?0.05).Conclusion Overage military flying personnel could apply for specially permitted aeromedical evaluation to extend their flying lifespan.Attention should be paid to metabolic and cardiovascular diseases in aeromedical support and evaluation for these experienced flying personnel.
8.Analysis of 3D slicer volume segmentation accuracy and perspect of application in forensic practice
Xin ZHAO ; Fengkai ZHANG ; Jiuming ZHANG ; Bo WANG ; Hongyang LI ; Hang MU ; Yong ZHANG ; Haichao ZHU ; Mingran QI ; Lijun WANG ; Yanbin GAO ; Zhiming CHEN
Chinese Journal of Forensic Medicine 2023;38(6):637-641
Objective To explore the effectiveness of virtual autopsy-based postmortem computed tomography(PMCT)liver three dimensional slicer(3D slicer)artificial intelligence(AI)volume reconstruction to assist forensic practice.Methods Twenty cases of the deceased who underwent both virtual autopsy and traditional autopsy in our center were selected and subjected to liver volume segmentation by 3D slicer method,Tada's formula method and literature method,and the data obtained from the traditional autopsy were compared and analyzed to obtain the accuracy rate.Results The 3D slicer method yielded higher consistency(95%confidence interval),lower volumetric variability(standard deviation),and a smaller region(variance)of uncertainty than the Tada formula method and the methods mentioned in the literature.Conclusion 3D slicer AI reconstruction based on virtual autopsy can visualize virtual anatomy,help increase the diagnostic accuracy of traditional autopsy,assist in pathological diagnosis,and provide new directions and tools for the development of imaging histology of virtual autopsy.
9.Paederosidic acid methyl ester inhibits hippocampal Nox4⁃mediated ferroptosis and improves postoperative learning and memory in mice
Tielong Liu ; Wenqiang Qi ; Hongyang Jiang ; Ruixue Wang ; Zhigang Dai ; Jiangwen Yin
Acta Universitatis Medicinalis Anhui 2023;58(7):1071-1076
Objective :
To investigate the effect of paederosidic acid methyl ester (PAME) on postoperative learning and memory impairment in mice and its mechanism.
Methods :
C57BL/6J male mice were randomly divided into Sham group , operation group , operation + PAME group ( PAME group) , operation + NADPH oxidase 4(Nox4) adeno⁃associated virus overexpression group (Nox4 overexpression group) , operation + Nox4 adeno⁃associated virus no⁃laden group ( AAV no⁃load group) , and operation + PAME + Nox4 overexpression group ( PN group) . Exploratory laparotomy was performed. PAME(20 mg/kg) was administered by continuous gavage for 7 days after operation , and adeno⁃associated virus was injected into the hippocampus 28 days before operation. Morris water maze test and conditioned fear test were used to detect the learning and memory ability of mice. The expression of Nox4 protein was observed by immunofluorescence. The protein expressions of Nox4 , long chain acyl CoA synthetase 4 (ACSL4) and glutathione peroxidase 4 (GPX4) were detected by Western blot. Reactive oxygen species (ROS) and iron content were determined by spectrophotometry.
Results :
Compared with the Sham group , the learning and memory ability of the operation group , the Nox4 overexpression group and the AAV no⁃load group decreased , the protein expression of Nox4 and ACSL4 increased , the protein expression of GPX4 decreased , and the ROS and iron content increased. After PAME treatment , the postoperative learning and memory ability of mice was improved , and Nox4 and ferroptosis in hippocampal neurons were alleviated.
Conclusion
Conclusion PAME treatment can improve the learning and memory ability of postoperative mice , which may be related to the inhibition of hippocampal Nox4⁃mediated ferroptosis.
10.Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood.
Shuzhen CHEN ; Yaping DONG ; Xinming QI ; Qiqi CAO ; Tao LUO ; Zhaofang BAI ; Huisi HE ; Zhecai FAN ; Lingyan XU ; Guozhen XING ; Chunyu WANG ; Zhichao JIN ; Zhixuan LI ; Lei CHEN ; Yishan ZHONG ; Jiao WANG ; Jia GE ; Xiaohe XIAO ; Xiuwu BIAN ; Wen WEN ; Jin REN ; Hongyang WANG
Acta Pharmaceutica Sinica B 2022;12(5):2252-2267
Aristolochic acids (AAs) have long been considered as a potent carcinogen due to its nephrotoxicity. Aristolochic acid I (AAI) reacts with DNA to form covalent aristolactam (AL)-DNA adducts, leading to subsequent A to T transversion mutation, commonly referred as AA mutational signature. Previous research inferred that AAs were widely implicated in liver cancer throughout Asia. In this study, we explored whether AAs exposure was the main cause of liver cancer in the context of HBV infection in mainland China. Totally 1256 liver cancer samples were randomly retrieved from 3 medical centers and a refined bioanalytical method was used to detect AAI-DNA adducts. 5.10% of these samples could be identified as AAI positive exposure. Whole genome sequencing suggested 8.41% of 107 liver cancer patients exhibited the dominant AA mutational signature, indicating a relatively low overall AAI exposure rate. In animal models, long-term administration of AAI barely increased liver tumorigenesis in adult mice, opposite from its tumor-inducing role when subjected to infant mice. Furthermore, AAI induced dose-dependent accumulation of AA-DNA adduct in target organs in adult mice, with the most detected in kidney instead of liver. Taken together, our data indicate that AA exposure was not the major threat of liver cancer in adulthood.


Result Analysis
Print
Save
E-mail